Skip to main content
Signal8

VSEE HEALTH, INC. (VSEE) Form 8-K — Jun 5, 2026

$VSEEForm 8-KItems 1.01, 2.01, 3.02, 5.02, 9.01Filed Jun 5, 2026, 4:15 PM ET0001185185-26-002359Original filing

VSee Health, Inc. has completed the sale of its wholly-owned subsidiary, VSee Lab, Inc., to Milton Chen, the company’s former co-CEO and Chairman. The transaction closed on May 31, 2026, under a Stock Purchase Agreement wherein Chen acquired all equity securities of VSee Lab in exchange for transferring his entire holding of 2,870,069 shares of VSee Health common stock to the company. Concurrent with the sale, Milton Chen resigned as co-CEO and Chairman of VSee Health.

Key figures

Shares Repurchased
2870069
Pro Forma Revenue FY 2025
7302954
Pro Forma Revenue Q1 2026
1879293
Closing Date
2026-05-31
Transaction Type
Sale of subsidiary VSee Lab to Milton Chen
Consideration Type
Transfer of 2,870,069 shares of VSee Health Common Stock owned by Chen

Price after filing

1 day: 0.0%7 days: -5.5%30 days: -33.3%

Close on the filing date to close N calendar days later (from $0.17). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.